Go Pro

Acumen Pharmaceuticals (ABOS) Institutional Ownership

Acumen Pharmaceuticals logo
$2.96 -0.20 (-6.17%)
As of 01:32 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Acumen Pharmaceuticals (NASDAQ:ABOS)

Current
Institutional Ownership
Percentage
71.01%
Number of
Institutional Buyers
(last 12 months)
24
Total
Institutional Inflows
(last 12 months)
$19.66M
Number of
Institutional Sellers
(last 12 months)
15
Total
Institutional Outflows
(last 12 months)
$4.98M
Get ABOS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Acumen Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

ABOS Institutional Buying and Selling by Quarter

Acumen Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
9/9/2026 Squarepoint Ops LLC52,351$140K0.0%+248.7%0.072%
9/8/2026 Spark Investment Management LLC14,700$39K0.1%N/A0.020%
8/21/2026 AXQ Capital LP24,426$65K0.0%-14.3%0.034%
8/20/2026 Two Sigma Securities LLC11,892$32K0.0%N/A0.016%
8/17/2026 Bank of America Corp DE274,781$734K0.0%N/A0.380%
8/14/2026 ADAR1 Capital Management LLC2,111,334$5.64M0.3%N/A2.923%
8/7/2026 BlackRock Inc.2,490,115$6.65M0.0%N/A3.447%
8/7/2026 Deutsche Bank AG46,132$123K0.0%N/A0.064%
8/6/2026 Bank of New York Mellon Corp124,377$332K0.0%N/A0.172%
5/19/2026 Bank of America Corp DE320,216$756K0.0%+33.3%0.443%
5/18/2026 ADAR1 Capital Management LLC2,156,334$5.09M0.3%+142.0%2.985%
5/15/2026 Rangeley Capital LLC35,000$83K0.1%N/A0.048%
5/15/2026 OMERS ADMINISTRATION Corp28,600$67K0.0%+27.4%0.040%
5/14/2026 Renaissance Technologies LLC473,946$1.12M0.0%+12.0%0.656%
5/14/2026 Sei Investments Co.11,564$27K0.0%N/A0.016%
5/7/2026 Dimensional Fund Advisors LP119,756$282K0.0%+144.1%0.166%
4/27/2026 PFG Investments LLC80,850$191K0.0%+325.5%0.112%
4/16/2026 SG Americas Securities LLC719,257$1.70M0.0%+79.3%0.996%
2/18/2026 XTX Topco Ltd49,563$105K0.0%N/A0.082%
2/18/2026 Ikarian Capital LLC254,312$537K0.0%-4.3%0.420%
2/18/2026 Quadrature Capital Ltd49,046$103K0.0%N/A0.081%
2/18/2026 Millennium Management LLC584,143$1.23M0.0%-2.9%0.964%
2/18/2026 Boothbay Fund Management LLC39,585$84K0.0%-22.4%0.065%
2/18/2026 Bridgeway Capital Management LLC170,171$359K0.0%-10.5%0.281%
2/16/2026 OMERS ADMINISTRATION Corp22,454$47K0.0%N/A0.037%
2/13/2026 Marshall Wace LLP20,907$44K0.0%N/A0.035%
2/13/2026 State Street Corp100,178$211K0.0%-6.1%0.165%
2/12/2026 Jane Street Group LLC142,123$300K0.0%-31.4%0.235%
2/12/2026 Renaissance Technologies LLC423,100$893K0.0%-27.6%0.699%
2/12/2026 Dimensional Fund Advisors LP49,062$104K0.0%+12.7%0.081%
2/10/2026 Goldman Sachs Group Inc.117,851$249K0.0%-19.9%0.195%
2/9/2026 Geode Capital Management LLC410,206$866K0.0%+2.9%0.677%
2/9/2026 Prospera Financial Services Inc50,000$106K0.0%N/A0.083%
2/4/2026 Independent Advisor Alliance19,000$40K0.0%N/A0.031%
1/26/2026 PFG Investments LLC19,000$40K0.0%+65.2%0.031%
12/15/2025 Hudson Bay Capital Management LP725,004$1.24M0.0%-12.1%1.197%
11/17/2025 Jacobs Levy Equity Management Inc.16,001$27K0.0%N/A0.026%
11/17/2025 Susquehanna International Group LLP214,440$367K0.0%+26.5%0.354%
11/17/2025 Qube Research & Technologies Ltd32,881$56K0.0%-42.9%0.054%
11/17/2025 Millennium Management LLC601,716$1.03M0.0%-69.1%0.993%
The end may be near for these iconic stocks (Ad)

Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required.tc pixel

Watch Marc Chaikin's free presentation and get his full buy-and-sell list today
11/17/2025 Bank of America Corp DE213,729$365K0.0%+45.4%0.353%
11/14/2025 ADAR1 Capital Management LLC891,183$1.52M0.1%-2.7%1.471%
11/14/2025 Bridgeway Capital Management LLC190,171$325K0.0%+65.1%0.314%
11/13/2025 Pathstone Holdings LLC859,110$1.47M0.0%-18.8%1.418%
11/13/2025 Franklin Resources Inc.2,305,096$3.94M0.0%-25.1%3.806%
11/7/2025Vanguard Group Inc.1,651,472$2.82M0.0%-2.2%2.727%
10/23/2025 SG Americas Securities LLC403,878$691K0.0%N/A0.667%
8/19/2025 Marex Group plc33,300$39K0.0%N/A0.055%
8/18/2025 Hudson Bay Capital Management LP825,004$957K0.0%+7.1%1.362%
8/15/2025 Hudson Bay Capital Management LP825,004$957K0.0%+7.1%1.362%
8/15/2025 Bank of America Corp DE147,009$171K0.0%-7.5%0.243%
8/14/2025 Jane Street Group LLC175,670$204K0.0%+1,526.0%0.290%
8/14/2025 Qube Research & Technologies Ltd57,559$67K0.0%+160.0%0.095%
8/13/2025 Marshall Wace LLP137,943$160K0.0%N/A0.228%
8/12/2025 Franklin Resources Inc.3,077,039$3.57M0.0%-2.1%5.080%
8/8/2025 Geode Capital Management LLC396,626$460K0.0%-54.0%0.655%
8/1/2025 Y Intercept Hong Kong Ltd250,848$291K0.0%N/A0.414%
6/27/2025 Goldman Sachs Group Inc.196,207$216K0.0%-10.5%0.324%
5/16/2025Goldman Sachs Group Inc.196,207$216K0.0%-10.5%0.324%
5/16/2025AQR Capital Management LLC41,735$46K0.0%N/A0.069%
5/16/2025ADAR1 Capital Management LLC146,183$161K0.0%+55.0%0.241%
5/12/2025Nuveen LLC78,446$86K0.0%N/A0.130%
5/12/2025Invesco Ltd.127,798$141K0.0%+544.1%0.211%
2/17/2025Two Sigma Investments LP301,268$518K0.0%-2.7%0.501%
2/17/2025Two Sigma Advisers LP499,100$858K0.0%+6.4%0.831%
2/17/2025Millennium Management LLC1,344,745$2.31M0.0%-26.7%2.238%
2/17/2025Deutsche Bank AG96,995$167K0.0%+468.7%0.161%
2/17/2025Bank of America Corp DE148,668$256K0.0%+7.2%0.247%
2/14/2025Jane Street Group LLC30,740$53K0.0%-116.1%0.051%
2/14/2025Susquehanna Fundamental Investments LLC14,731$25K0.0%N/A0.025%
2/14/2025Rock Springs Capital Management LP1,838,916$3.16M0.1%-20.0%3.061%
2/14/2025Tower Research Capital LLC TRC20,624$35K0.0%+427.5%0.034%
2/14/2025Dimensional Fund Advisors LP98,016$169K0.0%+73.3%0.163%
2/13/2025Barclays PLC93,082$161K0.0%+50.1%0.155%
2/13/2025Renaissance Technologies LLC257,213$442K0.0%-16.0%0.428%
2/13/2025ADAR1 Capital Management LLC94,294$162K0.0%N/A0.157%
2/12/2025Franklin Resources Inc.3,273,633$5.63M0.0%-7.8%5.449%
2/12/2025JPMorgan Chase & Co.937,908$1.61M0.0%+1,387.2%1.561%
2/11/2025Clune & Associates LTD.16,500$28K0.0%N/A0.027%
2/11/2025Intech Investment Management LLC18,847$32K0.0%N/A0.031%
2/6/2025Charles Schwab Investment Management Inc.126,747$218K0.0%+16.6%0.211%
1/30/2025Rhumbline Advisers53,076$91K0.0%-40.0%0.088%
1/17/2025SG Americas Securities LLC25,631$44K0.0%+44.2%0.043%
12/26/2024JPMorgan Chase & Co.63,066$156K0.0%+252.8%0.105%
11/27/2024Franklin Resources Inc.3,549,069$8.34M0.0%+5.4%5.907%
11/19/2024Barclays PLC61,997$154K0.0%+189.1%0.103%
11/16/2024Geode Capital Management LLC864,528$2.14M0.0%+6.5%1.439%
11/15/2024Barclays PLC61,997$154K0.0%+189.1%0.103%
11/15/2024State Street Corp516,406$1.28M0.0%+18.3%0.860%
11/13/2024FMR LLC2,028,117$5.03M0.0%+0.3%3.376%
Your book attached (Ad)

Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel

Download the Safe Trade Options Formula book for free before access closes
11/13/2024The Manufacturers Life Insurance Company52,333$130K0.0%-12.8%0.087%
10/3/2024SG Americas Securities LLC17,772$44K0.0%N/A0.030%
8/16/2024Murchinson Ltd.56,250$136K0.0%N/A0.094%
8/15/2024Millennium Management LLC1,954,085$4.73M0.0%-25.7%3.252%
8/14/2024Murchinson Ltd.56,250$136K0.0%N/A0.094%
8/12/2024Marathon Trading Investment Management LLC26,298$64K0.0%-56.2%0.044%
8/9/2024Renaissance Technologies LLC338,100$818K0.0%N/A0.563%
8/9/2024Dimensional Fund Advisors LP56,548$137K0.0%-8.4%0.094%
8/8/2024American Century Companies Inc.45,444$110K0.0%+31.3%0.076%
8/1/2024Rhumbline Advisers52,323$127K0.0%N/A0.087%


ABOS Institutional Ownership - Frequently Asked Questions

During the previous two years, 54 institutional investors and hedge funds held shares of Acumen Pharmaceuticals. The most heavily invested institutionals were BlackRock Inc. ($6.65M), ADAR1 Capital Management LLC ($5.64M), FMR LLC ($5.03M), Franklin Resources Inc. ($3.94M), Rock Springs Capital Management LP ($3.16M), Vanguard Group Inc. ($2.82M), and SG Americas Securities LLC ($1.70M).Learn more on Acumen Pharmaceuticals' institutional investors.

71.01% of Acumen Pharmaceuticals' stock is owned by institutional investors. Learn more on ABOS's institutional investor holdings.

Of the 43 institutional investors that purchased Acumen Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: ADAR1 Capital Management LLC ($3.52M), BlackRock Inc. ($2.49M), JPMorgan Chase & Co. ($920.03K), SG Americas Securities LLC ($747.72K), Bank of America Corp DE ($431.51K), Jane Street Group LLC ($386.01K), and Y Intercept Hong Kong Ltd ($250.85K).

Institutional investors have bought a total of 7,852,129 shares in the last 24 months. This purchase volume represents approximately $19.66M in transactions.

Of the 15 institutional investors that sold Acumen Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Millennium Management LLC ($1.37M), Franklin Resources Inc. ($771.94K), Pathstone Holdings LLC ($199.42K), Renaissance Technologies LLC ($161.19K), Hudson Bay Capital Management LP ($100K), Jane Street Group LLC ($65.12K), and Vanguard Group Inc. ($37.88K).

Institutional investors have sold a total of 2,833,978 shares in the last 24 months. This volume of shares sold represents approximately $4.98M in transactions.



Institutional ownership data for NASDAQ:ABOS is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 9/9/2026. New 13F filings are added each quarter as they're published.
From Our Partners